Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5406)
All Articles published online
|
Dec 6, 2012 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Scarpioni R, Ricardi M, Albertazzi V, Melfa L. Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins. World J Nephrol 2012; 1(6): 184-194 [PMID: 24175258 DOI: 10.5527/wjn.v1.i6.184] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v1/i6/184.htm |
| Number | Citing Articles |
| 1 |
Amir Ajoolabady, Domenico Pratico, Mohsen Mazidi, Ian G. Davies, Gregory Y.H. Lip, Nabil Seidah, Peter Libby, Guido Kroemer, Jun Ren. PCSK9 in metabolism and diseases. Metabolism 2024; : 156064 doi: 10.1016/j.metabol.2024.156064
|
| 2 |
Jasna Klen, Katja Goričar, Andrej Janež, Vita Dolžan. NLRP3Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients. Journal of Diabetes Research 2015; 2015: 1 doi: 10.1155/2015/616747
|
| 3 |
Y.E. Yoon, K.H. Choi, K.H. Kim, S.C. Yang, W.K. Han. Clinical Assessment of Lipid Profiles in Live Kidney Donors. Transplantation Proceedings 2015; 47(3): 584 doi: 10.1016/j.transproceed.2014.12.035
|
| 4 |
Andrew Kowalski, Armand Krikorian, Edgar V. Lerma. Dyslipidemia in chronic kidney disease. Disease-a-Month 2015; 61(9): 396 doi: 10.1016/j.disamonth.2015.07.004
|
| 5 |
Annalina Avram, Cátia Duarte, Maria José Santos, Charalampos Papagoras, Konstantinos Ritis, Roberto Scarpioni, Wolfgang A. Schmidt, Panagiotis Skendros. Identifying Patient Candidates for IL-1 Inhibition: Lessons From Real-World Cases. Joint Bone Spine 2015; 82: eS17 doi: 10.1016/S1297-319X(15)30004-X
|
| 6 |
Jianting Wang, Ziwei Chen, Yuliang Qiu, Ling Wu, Huan Wang, Lisheng Wu, Liangbin Zhao, Dengpiao Xie, Maria Irene Bellini. Statins Have an Anti-Inflammation in CKD Patients: A Meta-Analysis of Randomized Trials. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/4842699
|
| 7 |
Emily de S. Ferreira, Luciana S. da Silva, Glauce D. da Costa, Tiago R. Moreira, Luíza D. Borges, Rosângela M. M. Cotta. Dietary intake, anthropometric measurements, biochemistry profile and their associations with chronic kidney disease and diabetes mellitus. Journal of Nutritional Science 2020; 9 doi: 10.1017/jns.2020.38
|
| 8 |
Florian G. Scurt, Maximilian J. Ganz, Carolin Herzog, Katrin Bose, Peter R. Mertens, Christos Chatzikyrkou. Association of metabolic syndrome and chronic kidney disease. Obesity Reviews 2024; 25(1) doi: 10.1111/obr.13649
|
| 9 |
You-Jin Kim, Se-Hyun Oh, Ji-Sun Ahn, Ju-Min Yook, Chan-Duck Kim, Sun-Hee Park, Jang-Hee Cho, Yong-Lim Kim. The Crucial Role of Xanthine Oxidase in CKD Progression Associated with Hypercholesterolemia. International Journal of Molecular Sciences 2020; 21(20): 7444 doi: 10.3390/ijms21207444
|
| 10 |
Nancy J McGraw, Elaine S Krul, Elizabeth Grunz-Borgmann, Alan R Parrish. Soy-based renoprotection. World Journal of Nephrology 2016; 5(3): 233-257 doi: 10.5527/wjn.v5.i3.233
|
| 11 |
Zhongjie Wang, Wenhan Huang, Hui Li, Lin Tang, Hang Sun, Qi Liu, Ling Zhang. Synergistic action of inflammation and lipid dysmetabolism on kidney damage in rats. Renal Failure 2018; 40(1): 175 doi: 10.1080/0886022X.2018.1450763
|
| 12 |
Viviane Calice-Silva, Daniel Muenz, Michelle M. Y. Wong, Keith McCullough, David Charytan, Helmut Reichel, Bruce Robinson, Benedicte Stengel, Ziad A. Massy, Roberto Pecoits-Filho, Antonio Lopes, Christian Combe, Christian Jacquelinet, Ziad Massy, Johannes Duttlinger, Danilo Fliser, Gerhard Lonnemann, Takashi Wada, Kunihiro Yamagata, Ron Pisoni, Viviane Calice-Silva, Ricardo Sesso, Elodie Speyer, Natalia Alencar de Pinho, Koichi Asahi, Junichi Hoshino, Ichiei Narita, Rachel Perlman, Friedrich Port, Nidhi Sukul, Michelle Wong, Eric Young, Jarcy Zee. International practice patterns of dyslipidemia management in patients with chronic kidney disease under nephrology care: is it time to review guideline recommendations?. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01833-z
|
| 13 |
Akashkumar N Singh, Tatineni Swathi. Insights into the Association of Chronic Kidney Disease (CKD) and Cardiovascular Risk Among Diabetic vs Non-Diabetic Patients. Cardiovascular & Hematological Agents in Medicinal Chemistry 2023; 21(1): 10 doi: 10.2174/1871525720666220610160310
|
| 14 |
On Ying Angela Lee, Alex Ngai Nick Wong, Ching Yan Ho, Ka Wai Tse, Angela Zaneta Chan, George Pak-Heng Leung, Yiu Wa Kwan, Martin Ho Yin Yeung. Potentials of Natural Antioxidants in Reducing Inflammation and Oxidative Stress in Chronic Kidney Disease. Antioxidants 2024; 13(6): 751 doi: 10.3390/antiox13060751
|
| 15 |
Hyun Jung Koo, Se Chan Kang, Seon-A Jang, Jung-Eun Kwon, Eunsoo Sohn, Eun-Hwa Sohn. Effects of Protocatechuic Acid Derived from Rubus coreanus on the Lipid Metabolism in High Cholesterol Diet-induced Mice. Korean Journal of Plant Resources 2014; 27(4): 271 doi: 10.7732/kjpr.2014.27.4.271
|
| 16 |
Jasna Klen, Katja Goričar, Andrej Janež, Vita Dolžan. Common Polymorphisms in Antioxidant Genes are Associated with Diabetic Nephropathy in Type 2 Diabetes Patients. Personalized Medicine 2015; 12(3): 187 doi: 10.2217/pme.14.86
|
| 17 |
L. Gorman, L.C. Sharkey, P.J. Armstrong, K. Little, A. Rendahl. Serum Beta Hydroxybutyrate Concentrations in Cats with Chronic Kidney Disease, Hyperthyroidism, or Hepatic Lipidosis. Journal of Veterinary Internal Medicine 2016; 30(2): 611 doi: 10.1111/jvim.13826
|
| 18 |
Thomas A Bell, Mark J Graham, Brenda F Baker, Rosanne M Crooke. Therapeutic inhibition of apoC-III for the treatment of hypertriglyceridemia. Clinical Lipidology 2015; 10(2): 191 doi: 10.2217/clp.15.7
|
| 19 |
Denise K. Link. Management of the Chronic Kidney Disease Patient. Physician Assistant Clinics 2016; 1(1): 43 doi: 10.1016/j.cpha.2015.09.007
|
| 20 |
Vasilios G Athyros, Niki Katsiki, Asterios Karagiannis, Dimitri P Mikhailidis. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?. Expert Opinion on Pharmacotherapy 2015; 16(10): 1449 doi: 10.1517/14656566.2015.1053464
|
| 21 |
Neris Dincer, Tuncay Dagel, Baris Afsar, Adrian Covic, Alberto Ortiz, Mehmet Kanbay. The effect of chronic kidney disease on lipid metabolism. International Urology and Nephrology 2019; 51(2): 265 doi: 10.1007/s11255-018-2047-y
|
| 22 |
Roberto Scarpioni, Marco Ricardi, Vittorio Albertazzi. Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage. World Journal of Nephrology 2016; 5(1): 66-75 doi: 10.5527/wjn.v5.i1.66
|
| 23 |
Victoria López‐Olmos, Elizabeth Carreón‐Torres, María Luna‐Luna, Cristobal Flores‐Castillo, Miriam Martínez‐Ramírez, Rocío Bautista‐Pérez, Martha Franco, Julio Sandoval‐Zárate, Francisco‐Javier Roldán, Alberto Aranda‐Fraustro, Elizabeth Soria‐Castro, Mónica Muñoz‐Vega, José‐Manuel Fragoso, Gilberto Vargas‐Alarcón, Oscar Pérez‐Méndez. Increased HDL Size and Enhanced Apo A‐I Catabolic Rates Are Associated With Doxorubicin‐Induced Proteinuria in New Zealand White Rabbits. Lipids 2016; 51(3): 311 doi: 10.1007/s11745-016-4120-6
|
| 24 |
Samuel N Uwaezuoke, Uzoamaka V Muoneke, Ngozi R Mbanefo. <p>The Supportive Treatment of IgA Nephropathy and Idiopathic Nephrotic Syndrome: How Useful are Omega-3 Polyunsaturated Fatty Acids?</p>. International Journal of Nephrology and Renovascular Disease 2020; : 27 doi: 10.2147/IJNRD.S237527
|